Related Experiment Video
Updated: Jul 2, 2025

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model
Published on: October 16, 2017
PIN1 promotes the metastasis of cholangiocarcinoma cells by RACK1-mediated phosphorylation of ANXA2
Yuming Wang1,2, Yiwei Liu1,2, Hairong Chen3
1Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University; Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences; NHC Key Laboratory of Living Donor Liver Transplantation (Nanjing Medical University), 300 Guangzhou Road, Nanjing, China.
Background:
Cholangiocarcinoma (CCA), a primary hepatobiliary malignancy, is characterized by a poor prognosis and a lack of effective treatments. Therefore, the need to explore novel therapeutic approaches is urgent. While the role of Peptidylprolyl Cis/Trans Isomerase, NIMA-Interacting 1 (PIN1) has been extensively studied in various tumor types, its involvement in CCA remains poorly understood.
Methods:
In this study, we employed tissue microarray (TMA), reverse transcription-polymerase chain reaction (RT-PCR), and The Cancer Genome Atlas (TCGA) database to assess the expression of PIN1. Through in vitro and in vivo functional experiments, we investigated the impact of PIN1 on the adhesion and metastasis of CCA. Additionally, we explored downstream molecular pathways using RNA-seq, western blotting, co-immunoprecipitation, immunofluorescence, and mass spectrometry techniques.
Results:
Our findings revealed a negative correlation between PIN1 overexpression and prognosis in CCA tissues. Furthermore, high PIN1 expression promoted CCA cell proliferation and migration. Mechanistically, PIN1 functioned as an oncogene by regulating ANXA2 phosphorylation, thereby promoting CCA adhesion. Notably, the interaction between PIN1 and ANXA2 was facilitated by RACK1. Importantly, pharmacological inhibition of PIN1 using the FDA-approved drug all-trans retinoic acid (ATRA) effectively suppressed the metastatic potential of CCA cells in a nude mouse lung metastasis model.
Conclusion:
Overall, our study emphasizes the critical role of the PIN1/RACK1/ANXA2 complex in CCA growth and functionality, highlighting the potential of targeting PIN1 as a promising therapeutic strategy for CCA.
Insights
Peptidylprolyl Cis/Trans Isomerase, NIMA-Interacting 1 (PIN1) drives cholangiocarcinoma (CCA) growth and metastasis by regulating ANXA2 phosphorylation. Targeting PIN1 with all-trans retinoic acid (ATRA) shows therapeutic potential for CCA.
Area of Science:
- Hepatobiliary Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Cholangiocarcinoma (CCA) presents a significant clinical challenge due to poor prognosis and limited treatment options.
- The role of Peptidylprolyl Cis/Trans Isomerase, NIMA-Interacting 1 (PIN1) in CCA pathogenesis is largely unexplored.
- Identifying novel therapeutic targets is crucial for improving outcomes in CCA patients.
Purpose of the Study:
- To investigate the expression and function of PIN1 in cholangiocarcinoma.
- To elucidate the molecular mechanisms by which PIN1 influences CCA progression.
- To evaluate the therapeutic potential of targeting PIN1 in CCA.
Main Methods:
- Assessed PIN1 expression using tissue microarrays and TCGA data.
- Conducted in vitro and in vivo experiments to evaluate PIN1's role in CCA cell adhesion and metastasis.
- Utilized RNA-seq, western blotting, co-immunoprecipitation, immunofluorescence, and mass spectrometry to explore downstream pathways.
Main Results:
- PIN1 overexpression correlated with poor prognosis in CCA and promoted cell proliferation and migration.
- PIN1 acts as an oncogene by regulating ANXA2 phosphorylation, enhancing CCA cell adhesion.
- The PIN1/RACK1/ANXA2 complex was identified as a key mediator of CCA progression.
- Pharmacological inhibition of PIN1 with ATRA suppressed CCA metastasis in vivo.
Conclusions:
- The PIN1/RACK1/ANXA2 complex plays a critical role in CCA growth and metastasis.
- Targeting PIN1 represents a promising therapeutic strategy for cholangiocarcinoma.
- All-trans retinoic acid (ATRA) demonstrates potential as a PIN1 inhibitor for CCA treatment.
More Related Videos
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a...
Intracellular Signaling Affects Focal Adhesions
Some...
Anaphase Promoting Complex